News & events

Heroin injection associated with respiratory disorder

A single case study of an individual with longstanding heroin addiction has shown heroin-induced slow and ineffective breathing, as well as apnoea, in research from the NIHR Maudsley BRC.

By NIHR Maudsley BRC at 26 Mar 2020

10,000 people could benefit from new migraine drug

Fremanezumab, a new drug preventing chronic migraine, has been recommended in final draft guidance from National Institute for health and Care Excellence (NICE) today (12 March 2020) following clinical trials based on research led by King’s College London.

By NIHR Maudsley BRC at 12 Mar 2020

Study gets under way to test psilocybin for treatment-resistant depression

The NIHR-Wellcome Trust King's Clinical Research Facility has administered psilocybin to a patient with treatment-resistant depression in the first randomised controlled trial of its kind.

By NIHR Maudsley BRC at 17 Sep 2019

Celebrating the impact of clinical research

NIHR Maudsley BRC researchers, clinicians and health and social care staff celebrated clinical research at South London and Maudsley NHS Foundation Trust and at the King’s College NHS Foundation Trust for this year’s International Clinical Trials Day.

By NIHR Maudsley BRC at 21 May 2018

1 in 4 pregnant women have mental health problems

A new King’s College London study, funded by NIHR, published in the British Journal of Psychiatry, found that 1 in 4 pregnant women have mental health problems. This is more common than previously thought – but two simple questions can help identify these problems so that women can be treated.

By NIHR Maudsley BRC at 4 Jan 2018